Current through Register Vol. 43, No. 52, December 26, 2024
(a) Each
person licensed to practice the healing arts or engaged in a postgraduate
training program approved by the state board of healing arts, licensed dentist,
licensed professional nurse, licensed practical nurse, administrator of a
hospital, licensed adult care home administrator, licensed physician assistant,
licensed social worker, and teacher or school administrator shall report each
suspected case of the following infectious or contagious diseases or conditions
to the secretary within four hours of knowledge of the suspected case:
(6) meningococcal disease;
(8) novel influenza A virus
infection;
(9) plague
(Yersinia pestis);
(13) severe acute respiratory
syndrome-associated cor-onovirus (SARS-CoV);
(17) vaccinia, postvaccination infection or
secondary transmission;
(18) viral
hemorrhagic fevers, including Ebola virus, Marburg virus, Crimean-Congo
hemorrhagic fever virus, Lassa virus, Lujo virus, and any of the New World
arenaviruses; and
(19) any exotic
or newly recognized disease.
(b) Each person licensed to practice the
healing arts or engaged in a postgraduate training program approved by the
state board of healing arts, licensed dentist, licensed professional nurse,
licensed practical nurse, administrator of a hospital, licensed adult care home
administrator, licensed physician assistant, licensed social worker, and
teacher or school administrator shall report each occurrence of any of the
following to the secretary within four hours:
(1) Clusters, outbreaks, or
epidemics;
(2) possible terrorist
acts due to biological, chemical, or radiological agents;
(3) unexplained death suspected to be due to
an unidentified infectious agent; or
(4) any unusual disease or manifestation of
illness.
(c) Each person
specified in subsection (a) shall report each case of the infectious or
contagious diseases or conditions specified in this subsection to the secretary
within 24 hours, except that if the reporting period ends on a weekend or
state-approved holiday, the report shall be made to the secretary by 5:00 p.m.
on the next business day after the 24-hour period. Each report for the
following shall be required only upon receipt of laboratory evidence of the
infectious or contagious disease or condition, unless otherwise specified or
requested by the secretary:
(1) Acute flaccid
myelitis (report all suspected cases, regardless of laboratory
evidence);
(3) arboviral
disease, neuroinvasive and nonneuroinvasive, including California serogroup
virus disease, chikungunya virus, any dengue virus infection, eastern equine
encephalitis virus disease (EEE), Powassan virus disease, St. Louis
encephalitis virus disease (SLE), West Nile virus disease (WNV), western equine
encephalitis virus disease (WEE), and Zika virus;
(5) blood lead level, any results;
(6) brucellosis, including laboratory
exposures to
Brucella species;
(9) carbapenem-resistant bacterial infection
or colonization;
(10) carbon
monoxide poisoning (report all suspected cases, regardless of laboratory
evidence);
(12) chickenpox
(varicella) (report all suspected cases, regardless of laboratory
evidence);
(13)
Chlamydia
trachomatis infection;
(19) gonorrhea, including antibiotic
susceptibility testing results, if performed;
(20)
Haemophilus influenzae,
invasive disease;
(21)
Hansen's disease (leprosy) (report all suspected cases, regardless of
laboratory evidence);
(22)
hantavirus (report all suspected cases, regardless of laboratory
evidence);
(23) hemolytic uremic
syndrome, postdiarrheal (report all suspected cases, regardless of laboratory
evidence);
(24) hepatitis A, acute
hepatitis A (IgM antibody-positive laboratory results only);
(25) hepatitis B, acute, chronic, and
perinatal infections;
(26)
hepatitis B in pregnancy (report the pregnancy of each woman with hepatitis B
virus infection);
(27) hepatitis B
(report all positive, negative, and inconclusive results for children younger
than five years of age);
(32) human immunodeficiency virus
infection;
(33) human
immunodeficiency virus-positive cases (report either the CD4+ T-lymphocyte cell
counts or the CD4+ T-lymphocyte percent of total lymphocytes);
(34) human immunodeficiency virus infection
in pregnancy (report the pregnancy of each woman with human immunodeficiency
virus infection);
(35) human
immunodeficiency virus (report viral load of any value);
(36) influenza that results in the death of
any child under 18 years of age (report both suspected cases and cases,
regardless of laboratory evidence);
(43) Q fever, acute and chronic;
(46) shiga toxin-producing
Escherichia coli (STEC);
(48) spotted fever rickettsiosis;
(49) streptococcal toxic-shock
syndrome;
(50)
Streptococcus pneumoniae, invasive disease;
(51) syphilis, including congenital syphilis
(report all suspected cases, regardless of laboratory evidence);
(52) toxic-shock syndrome, other than
streptococcal;
(53) transmissible
spongioform encephalopathy (TSE) or prion disease (indicate causative agent, if
known);
(54) trichinellosis or
trichinosis (report all suspected cases, regardless of laboratory
evidence);
(55) tuberculosis
infection (report all suspected cases based on positive tuberculin skin test or
laboratory evidence);
(56)
tularemia, including laboratory exposures;
(58) vancomycin-intermediate
Staphylococcus aureus (VISA);
(59) vancomycin-resistant
Staphylococcus aureus (VRSA);
(60) vibriosis or non-cholera
Vibrio
species;
(62) whooping cough
(pertussis) (report all suspected cases, regardless of laboratory
evidence).
(d) Each
person specified in subsection (a) shall report the following information in a
manner specified by the secretary for any suspected case or case required to be
reported by subsection (a), (b), or (c):
(1)
The following personal information for each patient:
(A) First and last names and middle initial;
(B) address, including city,
state, and zip code;
(C) telephone
number, including area code;
(G) ethnicity (specify if hispanic or
non-hispanic ethnicity);
(I) date of onset
of symptoms; and
(2) type of
diagnostic tests;
(4) date of specimen
collection;
(5) site of specimen
collection;
(6) diagnostic test
results, including reference range, titer if quantitative procedures are
performed, and all available results concerning additional characterization of
the organism;
(8) name, address, and
telephone number of the attending physician; and
(9) any other necessary epidemiological
information and additional specimen collection or laboratory test results
requested by the secretary or local health officer.